R.B.M. Schasfoort

R.B.M. Schasfoort is a researcher at the TechMed Centre specializing in Applied Stem Cell Technologies. His work focuses on Surface Plasmon Resonance, antibody characterization, and cell binding affinity with applications in immunology and therapeutic development. Current research explores high-avidity antibody isolation and inflammatory disease modulation.

Recent publications demonstrate expertise in:

• Developing CCR8 peptide antagonists for acute liver injury treatment (2025)
• Designing nanowell platforms for antibody-producing cell sorting (2024)
• Refining gradient methods for cell binding analysis (2024)
• Investigating antibody affinity in COVID-19 severity (2022)

Research trends include label-free biosensing, macrophage targeting therapies, and affinity-based drug optimization. Key technologies involve molecular docking, epitope binning, and density gradient analysis.